No Prescription |
 |
 | ||
|
Aredia Generic Pamidronate |
|
| ||
No Prescription » Prescription Drugs 2 » Aredia Generic Pamidronate This medication is used to treat high blood calcium levels (hypercalcemia) that may occur with cancer. Pamidronate is also used to treat a certain type of bone disease (Paget's disease) and bone problems that may occur with certain cancers (breast cancer multiple myeloma). Pamidronate belongs to a class of drugs known as bisphosphonates. It works by reducing the amount of calcium released from your bones into your blood.How to use Pamidronate IVFollow all instructions for proper mixing and dilution with the correct IV fluids. Before using check this product visually for particles or discoloration. If either is present do not use the liquid. Do not mix this drug with solutions that contain calcium (e.g. lactated Ringer's solution). If you have questions regarding the use of this medication consult your pharmacist.Kidney tests should be performed before each dose of pamidronate is given. Give this medication by vein as directed by your doctor.The dosage is based on your medical condition and response to therapy. The dose should not be greater than 90 milligrams or be given over less than 2 hours. Doses that are higher than 90 milligrams doses given too quickly or previous use of this medication (or related drugs such as alendronate) increase the risk for kidney problems. (See also Side Effects and Precautions sections.) For high calcium levels one dose is usually given. If needed a repeat dose may be given after 7 days.For Paget's disease this drug is usually given once a day for 3 days or as directed by your doctor.For bone problems use as directed by your doctor.It may take up to 7 days before the full benefit of this drug takes effect.Learn how to store and discard needles and medical supplies safely. Consult your pharmacist for more details. Buy Aredia Generic Pamidronate and other Prescription Drugs 2 products online at Medstore. 22
About Aredia Generic Pamidronate: Product Type: Prescription Drugs 2 Aredia ( Generic Pamidronate ) Aredia (Generic Pamidronate) Generic Pamidronate 30mg/10ml 2 amps Generic Pamidronate Aredia
View more Prescription Drugs 2 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
